Kevin Outterson

Join Amanda Starc and Craig Garthwaite from Kellogg School of Management, alongside Kevin Outterson from Boston University, as they delve into the economics of drug pricing and its impact on innovation. They discuss Medicare's new negotiating powers, the financial labyrinth of antibiotic development, and the challenges pharmaceutical companies face when balancing public health needs and sustainable business models. The conversation reveals the complex trade-offs between affordability and medical advancements that define modern healthcare.